Daratumumab: new indications revolving around "off-targets"
Haematologica
.
2021 Dec 1;106(12):3032-3033.
doi: 10.3324/haematol.2021.279487.
Author
Yishai Ofran
1
Affiliation
1
Hebrew University Faculty of Medicine, Department of Hematology, Shaare Zedek Medical Center, Jerusalem.
PMID:
34348458
PMCID:
PMC8634197
DOI:
10.3324/haematol.2021.279487
No abstract available
Publication types
Comment
MeSH terms
ADP-ribosyl Cyclase 1
Antibodies, Monoclonal* / therapeutic use
Humans
Substances
Antibodies, Monoclonal
daratumumab
ADP-ribosyl Cyclase 1